MedTrace Logo

National Study of Moderate and Severe Von Willebrand Disease in the Netherlands

NCT00510042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2010-04-26

No results posted yet for this study

Summary

The objective of this study is to assess the clinical presentation, the treatment and the complications of the disease and treatment in moderate and severe von Willebrand disease. Another goal is to investigate the influence of von Willebrand disease on quality of life.

Conditions

  • Von Willebrand Disease

Sponsors & Collaborators

  • Foundation Haemophilia

    collaborator UNKNOWN

  • CSL Behring

    collaborator INDUSTRY

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Eva M de Wee, MD · Erasmus Medical Center

  • Frank WG Leebeek, MD, PhD · Erasmus Medical Center

  • Karin Fijn van Draat, MD, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Jeroen CJ Eikenboom, MD, PhD · Leiden University Medical Center

  • Arja de Goede-Bolder, MD · Erasmus Medical Center

  • Eveline P Mauser-Bunschoten, MD, PhD · Van Creveldkliniek, University Medical Center Utrecht

  • Karina Meijer, MD, PhD · University Medical Center Goningen

  • Britta Laros-van Gorkom, MD, PhD · University Medical Center St. Radboud Nijmegen

  • Johanna G van der Bom, PhD · Leiden University Medical Center

  • Manon A Degenaar-Dujardin, BA · Organization for Hemophilia Patients

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Completion
2009-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00510042 on ClinicalTrials.gov